Skip to content

Validation of the Rhinitis Control Scoring System (RCSS)

Validation of a Rhinitis Control Tool : the Rhinitis Control Scoring System (RCSS)

Status
Suspended
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT00967967
Acronym
RCSS
Enrollment
50
Registered
2009-08-28
Start date
2009-03-31
Completion date
2014-09-30
Last updated
2013-05-27

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Asthma, Rhinitis

Keywords

control, symptoms

Brief summary

Many patients suffering from allergic rhinitis do not recognize or perceive their symptoms. Instruments have been developed to assess quality of life in rhinitis, asthma or both, but there is a need to develop validated tools or methods to assess rhinitis control among rhinitis and/or asthmatic patients. The aim of this study is to assess the discriminative and evaluative properties of the RCSS in asthmatic patients with allergic rhinitis.

Detailed description

Allergic asthmatic subjects showing seasonal rhinitis symptoms will be recruited. The discriminative (internal consistency, cross sectional construct validity and reliability) and evaluative (responsiveness and longitudinal construct validity) properties of the RCSS will be evaluated as well as the relationship between rhinitis control and asthma control. RCSS will be completed at various time points during the seasonal allergic period.

Interventions

DRUGMedication Mometasone furoate and desloratadine

One month treatment with both drugs

Sponsors

Laval University
Lead SponsorOTHER

Study design

Allocation
NA
Intervention model
SINGLE_GROUP
Primary purpose
TREATMENT
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
18 Years to 65 Years
Healthy volunteers
No

Inclusion criteria

* asthma * seasonal allergic rhinitis

Exclusion criteria

* smoking * nasal polyposis

Design outcomes

Primary

MeasureTime frame
Discriminative (internal consistency, cross sectional construct validity and reliability) and evaluative (responsiveness and longitudinal construct validity) properties of the RCSS.March to November 2009

Secondary

MeasureTime frame
The relationship between rhinitis control and asthma control.March to November 2009

Countries

Canada

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Mar 2, 2026